Citation:
Fallahi-Sichani, M, JAL Flynn, JJ Linderman, and DE Kirschner. 2012. Differential Risk of Tuberculosis Reactivation among Anti-TNF Therapies Is Due to Drug Binding Kinetics and Permeability. The Journal of Immunology 188, no. 7: 3169-78.
Harvard Medical School
Department of Systems Biology
Sorger Lab
Warren Alpert Building, 200 Longwood Ave., Boston, MA 02115
Email:
mohammad_fallahisichani [AT] hms.harvard.edu
fallahi [AT] umich.edu
Department of Systems Biology
Sorger Lab
Warren Alpert Building, 200 Longwood Ave., Boston, MA 02115
Email:
mohammad_fallahisichani [AT] hms.harvard.edu
fallahi [AT] umich.edu
